Effects of combining low‑dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome

Zhao,Yue; Du,Botao; Jiang,Xiaoying; Ma,Mingxing; Shi,Liqing; Zhang,Qinxi; Zhou,Lili

doi:10.3892/mmr.2014.2570

Effects of combining low‑dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome

Authors:
- Yue Zhao
- Botao Du
- Xiaoying Jiang
- Mingxing Ma
- Liqing Shi
- Qinxi Zhang
- Lili Zhou
View Affiliations

Affiliations: Department of Reproductive Medicine, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China, The Fourth Ward of the Obstetrical Department, Harbin Red Cross Central Hospital, Harbin, Heilongjiang 150000, P.R. China
Published online on: September 16, 2014 https://doi.org/10.3892/mmr.2014.2570
Pages: 2372-2376

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the clinical value of low‑dose aspirin in combination with Tiao Jing Cu Yun pills in patients with polycystic ovary syndrome (PCOS) by measuring follicular peripheral blood flow parameters and the clinical efficacy. The study involved 78 infertile females with PCOS who were randomly divided into experimental (n=38) and control (n=40) groups. The subjects in the experimental group were treated with letrozole in combination with aspirin and Tiao Jing Cu Yun pills, and the control group was treated with letrozole alone. Transvaginal color Doppler ultrasonography was used to measure the endometrial thickness, pulsatility index (PI), resistance index (RI), peak systolic velocity and end diastolic velocity (EDV) of the follicular peripheral artery on the day of human chorionic gonadotropin administration. The patients who failed to become pregnant in the control group were reintegrated into the experimental group in the subsequent cycle and the clinical effect was observed. In the experimental group, subject perifollicular blood flow was more plentiful, and the PI and RI of the perifollicular blood flow were significantly reduced, while the EDV of the perifollicular blood flow and the rate of clinical pregnancy were markedly elevated compared with the subjects in the control group. Low‑dose aspirin combined with Tiao Jing Cu Yun pills effectively improved perifollicular artery blood flow, and enhanced the oocyte quality and rate of clinical pregnancy.

View Figures

View References

1	Archer JS and Chang RJ: Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 18:737–754. 2004. View Article : Google Scholar : PubMed/NCBI
2	Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES and Yildiz BO: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 89:2745–2749. 2004. View Article : Google Scholar : PubMed/NCBI
3	Hu WH, Qiao J, Wang LN and Tong J: Clinical features of the metabolic syndrome in patients with polycystic ovary syndrome. Beijing Da Xue Xue Bao. 42:159–163. 2010.(In Chinese).
4	Nahid L and Sirous K: Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol. 64:253–258. 2012.PubMed/NCBI
5	Nahid L and Sirous K: Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol. 64:253–258. 2012.PubMed/NCBI
6	Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reprod. 19:41–47. 2004. View Article : Google Scholar
7	Azziz R, Carmina E, Dewailly D, et al: Androgen Excess Society: Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 91:4237–4245. 2006. View Article : Google Scholar
8	Health industry standard of the People’s Republic. Diagnosis of the polycystic ovary syndrome (WS 330–2011). The Ministry of Health Medical Service Standard Professional Committee of the People’s Republic of China; 2011
9	Zhang XN: Research on uterine and ovarian arterial blood flow for kidney-tonification and blood stasis-elimination treatment of polycystic ovarian syndrome. Chin J Pract Med. 26:864–867. 2010.(In Chinese).
10	Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 23:462–477. 2008. View Article : Google Scholar : PubMed/NCBI
11	Goldenberg N and Glueck C: Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation. Minerva Ginecol. 60:63–75. 2008.PubMed/NCBI
12	Borini A, Maccolini A, Tallarini A, Bonu MA, Sciajno R and Flamigni C: Perifollicular vascularity and its relationship with oocyte maturity and IVF outcome. Ann NY Acad Sci. 943:64–67. 2001. View Article : Google Scholar : PubMed/NCBI
13	Jokubkiene L, Sladkevicius P, Rovas L and Valentin L: Assessment of changes in volume and vascularity of the ovaries during the normal menstrual cycle using three-dimensional power Doppler ultrasound. Hum Reprod. 21:2661–2668. 2006.
14	Otsuki J, Okada A, Morimoto K, Nagai Y and Kubo H: The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod. 19:1591–1597. 2004. View Article : Google Scholar
15	Kurjak A, Kupesic-Urek S, Schulman H and Zalud I: Transvaginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women. Fertil Steril. 56:870–873. 1991.PubMed/NCBI
16	Du B, Takahashi K, Ishida GM, Nakahara K, Saito H and Kurachi H: Usefulness of intraovarian artery pulsatility and resistance indices measurement on the day of follicle aspiration for the assessment of oocyte quality. Fertil Steril. 85:366–370. 2006. View Article : Google Scholar
17	Ozturk O, Greaves M and Templeton A: Aspirin dilemma. Remodelling the hypothesis from a fertility perspective. Hum Reprod. 17:1146–1148. 2002. View Article : Google Scholar : PubMed/NCBI
18	Saito H, Kaneko T, Kawachiya S, Du B, Ishida GM and Kurachi H: Effects of aspirin on the oocyte quality. Fertil Steril. 76:S1312001. View Article : Google Scholar
19	Patrono C, García Rodríguez LA, Landolfi R and Baigent C: Low-dose aspirin for the prevention of atherosclerosis. N Engl J Med. 353:2373–2383. 2005. View Article : Google Scholar : PubMed/NCBI
20	Daya S: Is there a benefit of low-dose aspirin in assisted reproduction? Curr Opin Obstet Gynecol. 18:313–318. 2006. View Article : Google Scholar : PubMed/NCBI
21	Lai Q: 96 cases of clinical observation on Tiao Jing Cu Yun pills treatment for ovulation inhibition. Chin J Cosmetic Med. 20:3532011.
22	Xu ZM, Zhou YH and Peng JY: Curative effect observation on Tiao Jing Cu Yun pills for polycystic ovarian syndrome. Chin J Shanxi Trad Chi Med. 27:18–19. 2004.(In Chinese).
23	Isaacs JD Jr, Wells CS, Williams DB, Odem RR, Gast MJ and Strickler RC: Endometrial thickness is a valid monitoring parameter in cycles of ovulation induction with menotropins alone. Fertil Steril. 65:262–266. 1996.PubMed/NCBI